Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial

Autor: Roland Tubiana, Laurent Mandelbrot, Jérome Le Chenadec, Sandrine Delmas, Christine Rouzioux, Deborah Hirt, Jean-Marc Treluyer, Dieudonné Ekoukou, Eda Bui, Marie-Laure Chaix, Stéphane Blanche, Josiane Warszawski, J Ngondi, N Chernai, JP Teglas, C Laurent, P Huyn, J Le Chenadec, S Delmas, J Warszawski, P Muret, Y Baazia, V Jeantils, E Lachassine, A Rodrigues, A Sackho, I Sagnet-Pham, S Tassi, D Breilh, X Iriard, G Andre, D Douard, S Reigadas, D Roux, I Louis, P Morlat, S Pedebosq, J Barre, E Estrangin, E Fauveau, V Garrait, P Ledudal, C Pichon, L Richier, A Thebault, C Touboul, D Bornarel, V Chambrin, L Clech, P Dubreuil, L Foix L'helias, O Picone, H Schoen, M Stralka, C Crenn-Hebert, C Floch-Tudal, E Hery, H Ichou, L Mandelbrot, F Meier, V Tournier, S Walter, P Chevojon, A Devidas, M Granier, M Khanfar-boudjemai, C Malbrunot, R Nguyen, B Ollivier, E Radideau, I Turpault, T Jault, A Barrail, C Colmant, C Fourcade, C Goujard, C Pallier, D Peretti, AM Taburet, L Bocket, S D'angelo, F Godart, Y Hammou, N Houdret, F Mazingue, B Thielemans, C Brochier, L Cotte, F Januel, T Le Thi, MC Gagneux, A Bozio, J Massardier, K Kebaïli, Akli K Ben, B Heller-Roussin, C Riehl, S Roos, F Taccot, C Winter, J Arias, C Brunet-François, E Dailly, L Flet, V Gournay, F Mechinaud, V Reliquet, N Winner, G Peytavin, C Bardin, N Boudjoudi, A Compagnucci, C Guerin, A Krivine, E Pannier, D Salmon, JM Treluyer, G Firtion, D Ayral, N Ciraru-Vigneron, MC Mazeron, N Rizzo Badoin, H Trout, A Benachi, C Boissand, D Bonnet, S Boucly, S Blanche, ML Chaix, C Duvivier, S Parat, V Cayol, S Oucherif, C Rouzioux, JP Viard, M Bonmarchand, I De Montgolfier, M Dommergues, MH Fievet, M Iguertsira, M Pauchard, F Quetin, C Soulie, R Tubiana, A Faye, S Magnier, E Bui, B Carbonne, A Daguenel Nguyen, N Harchi, MC Meyohas, JM Poirier, J Rodriguez, F Hervé, G Pialloux, A Dehee, C Dollfus, I Tillous Borde, G Vaudre, A Wallet, MC Allemon, P Bolot, A Boussairi, C Chaplain, D Ekoukou, N Ghibaudo, JM Kana, MA Khuong, M Weil, N Entz-Werle, P Livolsi Lutz, L Beretz, M Cheneau, ML Partisani, MP Schmitt, P Acar, E Armand, A Berrebi, C Guibaud Plo, M Lavit, F Nicot, J Tricoire, F Ajana, T Huleux

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 57(6)

BACKGROUND Prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) is usually based on zidovudine-containing regimens, despite potential toxicities. This multicenter trial evaluated whether lopinavir/ritonavir (LPV/r)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c27cb3c232cccb3a346136fa0c3cdea
https://pubmed.ncbi.nlm.nih.gov/23766338

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.